Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis

Ruicai Gu1, Tae-Dong Kim1, Hanlin Jiang2

  • 1Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.

Frontiers in Oncology
|December 4, 2023
PubMed

Insights

JMJD2D epigenetic regulator overexpression fuels prostate cancer growth. Lysine methylation of JMJD2D impacts cancer cell behavior and influences CBLC gene expression, highlighting potential therapeutic targets for prostate cancer treatment.

Area of Science:

  • Epigenetics
  • Molecular Oncology
  • Biochemistry

Background:

  • The role of the JMJD2D epigenetic regulator in prostate cancer remains unclear.
  • Understanding JMJD2D regulation is crucial for identifying new therapeutic strategies.

Purpose of the Study:

  • To investigate the regulation and function of JMJD2D in prostate cancer.
  • To elucidate the downstream effects of JMJD2D activity on cancer progression.

Main Methods:

  • Analysis of JMJD2D expression in prostate tumors.
  • Site-directed mutagenesis of JMJD2D at K427.
  • Cell growth, invasion, and tumor formation assays.
  • Transcriptomic analysis.
  • Bioinformatic analyses of gene expression.

Main Results:

  • JMJD2D is overexpressed in prostate tumors and promotes cancer cell growth.
  • Lysine methylation of JMJD2D at K427 by SET7/9 regulates its oncogenic function.
  • K427 mutation in JMJD2D impairs DU145 cell growth, invasion, and tumor formation.
  • JMJD2D activity influences the expression of CBLC (a ubiquitin ligase) and PLAGL1 (a transcription factor).
  • CBLC is upregulated in prostate tumors and its downregulation mimics the effects of the K427 mutation.

Conclusions:

  • A novel regulatory mechanism for JMJD2D via lysine methylation has been identified.
  • JMJD2D's pro-tumorigenic role in prostate cancer is mediated partly through regulation of CBLC expression.
  • CBLC exhibits a pro-tumorigenic role in prostate cancer, suggesting it as a potential therapeutic target.
  • JMJD2D and CBLC inhibitors may offer therapeutic benefits for prostate cancer treatment.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.6K